Molly Browne
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- Signaling Pathways in Disease 3
- Cancer-related gene regulation 2
-
- Protease and Inhibitor Mechanisms 7
- Co-authors
- Roy H. Burdon (3 shared papers)Ian B. Dodd (10 shared papers)J.H. Robinson (10 shared papers)C.G. Chapman (8 shared papers)A. W. R. TYRRELL (2 shared papers)B. Reavy (2 shared papers)Andrew Godkin (2 shared papers)Ann Ager (2 shared papers)
- Journals
- Nucleic Acids Research (2 papers)Cancer Immunology Research (2 papers)Thrombosis and Haemostasis (2 papers)FEBS Letters (2 papers)Thrombosis Research (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Molly Browne
21 papers receiving 432 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 141
- Hematology 94
- Immunology 117
- Oncology 113
- Biotechnology 34
Countries citing papers authored by Molly Browne
This map shows the geographic impact of Molly Browne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Browne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Browne more than expected).
Fields of papers citing papers by Molly Browne
This network shows the impact of papers produced by Molly Browne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Browne. The network helps show where Molly Browne may publish in the future.
Co-authors
The 25 scholars most cited alongside Molly Browne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 98 | |
| 2 | 1988 | 70 | |
| 3 | 1996 | 49 | |
| 4 | 1977 | 39 | |
| 5 | 2019 | 30 | |
| 6 | 1986 | 29 | |
| 7 | 1985 | 27 | |
| 8 | 1977 | 26 | |
| 9 | 2017 | 22 | |
| 10 | 1985 | 21 | |
| 11 | 1978 | 14 | |
| 12 | 1990 | 13 | |
| 13 | 2020 | 13 | |
| 14 | 1989 | 13 | |
| 15 | 1992 | 7 | |
| 16 | 2020 | 7 | |
| 17 | 2024 | 5 | |
| 18 | 1991 | 3 | |
| 19 | 1993 | 1 | |
| 20 | 1993 | 1 |
About Molly Browne
Molly Browne is a scholar working on Molecular Biology, Cancer Research, Hematology, Pulmonary and Respiratory Medicine and Oncology, having authored 22 papers that have together received 489 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Signaling Pathways in Disease (3 papers), T-cell and B-cell Immunology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer-related gene regulation (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (141 citations), Hematology (94 citations), Immunology (117 citations), Oncology (113 citations) and Biotechnology (34 citations). Molly Browne has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Roy H. Burdon, Ian B. Dodd, J.H. Robinson, C.G. Chapman, A. W. R. TYRRELL, B. Reavy, Andrew Godkin, Ann Ager, Awen Gallimore and Kathryn Smart. Their work appears in journals such as Nucleic Acids Research, Cancer Immunology Research, Thrombosis and Haemostasis, FEBS Letters and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.